Operating Lease, Liability, Noncurrent of HERON THERAPEUTICS, INC. /DE/ from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • HERON THERAPEUTICS, INC. /DE/ Operating Lease, Liability, Noncurrent for the quarter ending 30 Sep 2024 was $522,000, a 85% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $522,000 -$3,015,000 -85% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,289,000 -$2,869,000 -69% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $2,045,000 -$2,786,000 -58% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $2,800,000 -$2,699,000 -49% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $3,537,000 -$2,614,000 -42% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $4,158,000 -$2,622,000 -39% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $4,831,000 -$2,560,000 -35% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,499,000 -$2,497,000 -31% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $6,151,000 -$6,066,000 -50% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $6,780,000 -$6,233,000 -48% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,391,000 -$6,399,000 -46% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $7,996,000 -$6,565,000 -45% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $12,217,000 -$3,081,000 -20% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $13,013,000 -$2,999,000 -19% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $13,790,000 -$2,918,000 -17% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $14,561,000 +$2,319,000 +19% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $15,298,000 +$4,515,000 +42% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $16,012,000 +$4,761,000 +42% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $16,708,000 +$4,985,000 +43% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $12,242,000 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $10,783,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $11,251,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $11,723,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.